Leslee Joyce Blaze, CRNP

Leslee Blaze practices at Mercy Behavorial Health in Pittsburgh, Pennsylvania.

Leslee Blaze's NPI, 1265535744, was assigned on September 7, 2006. Leslee Blaze holds Pennsylvania license SP0078900.

Leslee Blaze's primary practice is Mercy Behavorial Health, at 1200 Reedsdale St, Pittsburgh, PA 15233. The practice phone is (412) 697-3260.

Leslee Blaze's primary practice is Mercy Behavorial Health in Pittsburgh, Pennsylvania. The medical group on file is Thriveworks Counseling & Child Therapy Lynchburg. Dmand AI also links Leslee Blaze to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Leslee Blaze practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Leslee Blaze's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Leslee Blaze is licensed in Pennsylvania.

CMS data shows 163 Medicare services from Leslee Blaze across 2 procedure codes in 2024, all of them office visits, for 38 Medicare patients. Medicare paid $7,301 for them. Every service was in an office.

CMS counts 38 Medicare patients who saw Leslee Blaze in 2024. The largest group is under 65, with 20 patients. 53% of them have high cholesterol, and 47% have high blood pressure. 68% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Leslee Blaze's median patient age at 60, with 51% women.

In 2024, Leslee Blaze wrote 6,830 Medicare Part D claims for 249 patients. 93% of them were for generic drugs. CMS names the drug for 6,755 of them, across 64 drugs with 11 or more claims each, at $1,376,373 in total drug cost. In 2023, CMS named 6,805 claims across 65 drugs.

Leslee Blaze accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Leslee Blaze as offering telehealth.

CMS Open Payments shows 14 general payments to Leslee Blaze from 6 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Neurocrine BioSciences, Inc. paid the most, $267.